The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc. has recently revealed details regarding its interest in Mural Oncology plc under the Irish Takeover Panel's regulations. According to Form 8.3 disclosed on August 1, 2025, Vanguard holds 772,339 ordinary shares in Mural Oncology, equivalent to a 4.47% interest.

The disclosure was made to comply with Rule 8.3 of the Irish Takeover Panel Act, 1997, which mandates transparency for entities with stakes of 1% or more in another company. The shares, categorized as $0.01 ordinary shares, are the only securities Vanguard reported owning.

No dealings in cash-settled derivatives, stock-settled derivatives, or other securities were disclosed, and no other agreements or arrangements related to relevant securities were mentioned. Vanguard's position was last updated as of July 31, 2025.